IMO, the Biofrontera IPO schtick is a no deal where the pps of this pig is concerned. Nothing from that schtick will jack up the pps for the simple reason that all the current bruhaha about that IPO has had absolutely no positive effect on the pps.
The EPO schtick is the next fall back position for salvation of this investment. I do not see how that will ever be brought into reality because there is no way the happy managers are going to be able to scare up the $500 million required to bring that schtick into commercial realization.
JMHO, but I welcome any contrary thoughts which you might want to provide for my objective consideration.